MRNS
Marinus Pharmaceuticals Inc
Price:  
0.55 
USD
Volume:  
765,895.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MRNS EV/EBITDA

-3818.5%
Upside

As of 2025-02-09, the EV/EBITDA ratio of Marinus Pharmaceuticals Inc (MRNS) is -0.36. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNS's latest enterprise value is 43.33 mil USD. MRNS's TTM EBITDA according to its financial statements is -121.83 mil USD. Dividing these 2 quantities gives us the above MRNS EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.6x - 8.7x 8.2x
Forward P/E multiples 7.2x - 14.2x 10.1x
Fair Price (17.01) - (19.48) (20.43)
Upside -3195.9% - -3645.8% -3818.5%
0.55 USD
Stock Price
(20.43) USD
Fair Price

MRNS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-02-07 -0.36
2025-02-06 -0.36
2025-02-05 -0.36
2025-02-04 -0.35
2025-02-03 -0.35
2025-01-31 -0.35
2025-01-30 -0.35
2025-01-29 -0.35
2025-01-28 -0.35
2025-01-27 -0.35
2025-01-24 -0.35
2025-01-23 -0.35
2025-01-22 -0.35
2025-01-21 -0.35
2025-01-17 -0.35
2025-01-16 -0.35
2025-01-15 -0.35
2025-01-14 -0.35
2025-01-13 -0.35
2025-01-10 -0.35
2025-01-08 -0.35
2025-01-07 -0.35
2025-01-06 -0.35
2025-01-03 -0.35
2025-01-02 -0.35
2024-12-31 -0.35
2024-12-30 -0.35
2024-12-27 -0.27
2024-12-26 -0.25
2024-12-24 -0.22
2024-12-23 -0.21
2024-12-20 -0.21
2024-12-19 -0.21
2024-12-18 -0.22
2024-12-17 -0.22
2024-12-16 -0.22
2024-12-13 -0.23
2024-12-12 -0.23
2024-12-11 -0.24
2024-12-10 -0.23
2024-12-09 -0.24
2024-12-06 -0.24
2024-12-05 -0.23
2024-12-04 -0.24
2024-12-03 -0.25
2024-12-02 -0.26
2024-11-29 -0.25
2024-11-27 -0.25
2024-11-26 -0.25
2024-11-25 -0.25